INTENSIFICATION WITH INSULIN GLARGINE 300 U/ML (Gla-300) OR FIRST- GENERATION BASAL INSULINS (BIs) IN PEOPLE WITH TYPE 2 DIABETES (T2D) ON ONCE-WEEKLY GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RAs): DELIVER NEW-G

被引：0

作者：

Umpierrez, G. ^{[1
]}

Bailey, T. ^{[2
]}

Mahieu, A. ^{[3
]}

Li, X. ^{[4
]}

Mabunay, M. A. ^{[5
]}

Fonseca, V ^{[6
]}

机构：

[1] Emory Univ, Sch Med, Atlanta, GA USA

[2] AMCR Inst, Escondido, CA USA

[3] Sanofi, Paris, France

[4] Sanofi, Bridgewater, NJ USA

[5] Sanofi, Singapore, Singapore

[6] Tulane Univ, Med Ctr, New Orleans, LA USA

来源：

VALUE IN HEALTH | 2024年 / 27卷 / 06期

关键词：

D O I：

暂无

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

EE139

引用

页码：S83 / S83

页数：1

共 50 条

[1] Real-world outcomes of addition of insulin glargine 300 U/mL (Gla-300) to glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy in people with type 2 diabetes: The DELIVER-G study
Bailey, Timothy S.
Gill, Jasvinder
Jones, Merwyn S.
Shenoy, Laxmi
Nicholls, Charlie
Westerbacka, Jukka
DIABETES OBESITY & METABOLISM, 2022, 24 (08): : 1617 - 1622
[2] Safety of once-weekly glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes
Patel, Dhiren
JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2018, 30 : S29 - S42
[3] Safety of Once-weekly Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes
Frias, Juan Pablo
JOURNAL OF FAMILY PRACTICE, 2018, 67 (06): : S25 - S34
[4] Early use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in Type 2 diabetes
Ross, Stuart A.
Ballantine, Jane
CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (12) : 1617 - 1626
[5] Older Adults with Type 2 Diabetes (T2D) Experience Less Hypoglycemia when Switching to Insulin Glargine 300 U/mL (Gla-300) vs. Other Basal Insulins (DELIVER 3 Study)
Zhou, Fang Liz
Ye, Fen
Gupta, Vineet
Gupta, Rishab
Sung, Jennifer
Berhanu, Paulos
Blonde, Lawrence
DIABETES, 2017, 66 : A256 - A256
[6] Clinical Efficacy of Once-weekly Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes
Bailey, Timothy S.
JOURNAL OF FAMILY PRACTICE, 2018, 67 (06): : S14 - S24
[7] The mode and mechanism of action of once-weekly glucagon-like peptide-1 receptor agonists in type 2 diabetes
Ridge, Terry
JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2018, 30 : S12 - S18
[8] Glycaemic control in people with type 2 diabetes (T2D) switching from NPH to insulin glargine 300 U/mL (Gla-300): REALI pooled database
Mueller-Wieland, D.
Freemantle, N.
Bonadonna, R.
Mauquoi, C.
Bigot, G.
Bonnemaire, M.
Gourdy, P.
Mauricio, D.
DIABETOLOGIA, 2022, 65 (SUPPL 1) : S333 - S334
[9] DOSING PATTERNS AMONG PATIENTS WITH TYPE 2 DIABETES (T2D) INITIATING GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RAS) IN FRANCE AND THE NETHERLANDS
Norrbacka, K.
Divino, V
Lebrec, J.
Vadher, K.
DeKoven, M.
VALUE IN HEALTH, 2021, 24 : S84 - S84
[10] TREATMENT AND DOSING PATTERNS AMONG PATIENTS WITH TYPE 2 DIABETES (T2D) INITIATING GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RAS) IN SEVERAL COUNTRIES
Norrbacka, K.
Divino, V
Boye, K.
Lebrec, J.
Dekoven, M.
VALUE IN HEALTH, 2018, 21 : S137 - S137

← 1 2 3 4 5 →